ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,626.02
0.54%
US Tech 100
18,986.40
0.30%
Dow Jones
41,393.78
0.72%
Brent Oil
71.825
0.00%
Bitcoin
60,025.42
-0.91%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. GH Research PLC (GHRS) Quote

GH Research PLC

GH Research PLC (GHRS)

NASDAQ
8.30
-0.16
(-1.89%)
Closed September 14 4:00PM
Delayed by 15 minutes
8.05
-0.25
(-3.01%)
After Hours: 7:59PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
8.30
Bid
7.62
Ask
10.00
Volume
22,859
7.83 Day's Range 8.6851
5.05 52 Week Range 30.43
Market Cap
431.834M
Previous Close
8.46
Open
8.52
Last Trade
794
@
8.3
Last Trade Time
Financial Volume
$ 191,040
VWAP
8.3573
Average Volume (3m)
63,194
Shares Outstanding
52,028,145
Dividend Yield
-
PE Ratio
-11.77
Earnings Per Share (EPS)
-0.68
Revenue
-
Net Profit
-35.59M

About GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ghres.com
Headquarters
Dublin, Irl
Founded
-
GH Research PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GHRS. The last closing price for GH Research was $8.46. Over the last year, GH Research shares have traded in a share price range of $ 5.05 to $ 30.43.

GH Research currently has 52,028,145 shares outstanding. The market capitalization of GH Research is $440.16 million. GH Research has a price to earnings ratio (PE ratio) of -11.77.

Ask ADVFN Intelligence (AI)

GHRS Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 09 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 03 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 03 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 03 2024
Edgar (US Regulatory)

GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and expected completion of 6-month open-label...

September 03 2024
GlobeNewswire Inc.

GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer

DUBLIN, Ireland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and...

September 03 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 15 2024
Edgar (US Regulatory)

GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...

May 03 2024
GlobeNewswire Inc.

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

March 07 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

February 29 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.5-15.3061224499.812.2857.83301949.652105CS
4-3.42-29.18088737211.72147.833488911.07039434CS
12-0.95-10.27027027039.2514.997.836319411.37650416CS
26-2.03-19.65150048410.3314.995.05837159.01017481CS
52-14.94-64.285714285723.2430.435.058186213.20314438CS
156-13.7-62.27272727272230.435.058274613.7344636CS
2600009.095000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NOVVUNova Vision Acquisition Corporation
$ 41.00
(207.35%)
17.4k
NOVVNova Vision Acquisition Corporation
$ 37.0001
(200.08%)
202.75k
SMXSMX Security Matters Public Company
$ 5.85
(138.78%)
49.72M
OMICSingular Genomics Systems Inc
$ 12.38
(119.12%)
2.72M
TILInstill Bio Inc
$ 84.75
(82.41%)
3.76M
GSIWGarden Stage Ltd
$ 2.9693
(-75.66%)
4.21M
UPCUniverse Pharmaceuticals Inc
$ 0.55
(-67.07%)
29.83M
VMARVision Marine Technologies Inc
$ 0.77
(-48.67%)
30.61M
PRLDPrelude Therapeutics Inc
$ 2.775
(-42.55%)
2.49M
CNEYCN Energy Group Inc
$ 0.4335
(-37.17%)
4.79M
NVDANVIDIA Corporation
$ 119.10
(-0.03%)
238.43M
XXII22nd Century Group Inc
$ 0.3447
(28.00%)
183.73M
IMRXImmuneering Corporation
$ 2.02
(41.26%)
136.36M
SQQQProShares UltraPro Short QQQ
$ 8.17
(-1.33%)
127.78M
MULNMullen Automotive Inc
$ 0.1328
(-20.48%)
120.81M

Discussion

View Full Feed
blackhawks blackhawks 4 minutes ago
It appears Harris has finally hit the magic number in a major national poll post-debate:

New Yahoo News/YouGov poll: After debate, Harris surges to 5-point lead over Trump among registered voters in head-to-head matchup

Harris’s lead, her biggest yet, is similar among l
Monksdream Monksdream 4 minutes ago
AVBP recent ipo
https://investorshub.advfn.com/uimage/uploads/2024/9/14/yfzeyIMG_1788.gif
Eli's Gone Eli's Gone 4 minutes ago
I'm in: 16-45-13-19
nilremerlin nilremerlin 5 minutes ago
https://www.marijuanamoment.net/nixon-admitted-marijuana-is-not-particularly-dangerous-in-newly-discovered-recording/
AYRWF
WFD Capital WFD Capital 5 minutes ago
Stop the cap.
NSAV
show_me_money show_me_money 5 minutes ago
Bitcoin ceo? No such thing. Burn Bitcoin? Not how it works.
BTCUSD
luckydude777 luckydude777 5 minutes ago
You might have read this already: https://seekingalpha.com/article/4721046-sqqq-can-bring-trading-appeal-during-the-upcoming-fed-meeting?mailingid=36737188&messageid=must_reads&serial=36737188.1289499&source=email_must_reads&utm_campaign=Must%2BReads%2Brecurring%2B2024-09-14&utm_content=seeking_alp
SQQQ
SSKILLZ1 SSKILLZ1 6 minutes ago
Meanwhile the mets just blew the lead had a 4-0 lead, now down 5-4. And we know they will pay for this because they never get any help if they lose.
HGilS HGilS 6 minutes ago
Phucking idiot !!!

You are always right. Got it!!
You never added any value to this board.

Ignored.
ELTP
trippininLaCoste trippininLaCoste 6 minutes ago
If I were inside a college or NFL football stadium right now, how much would a shrimp sandwich cost a football fan if the stadium caterers paid $10 or $15 per pound for shrimp ?

If I were a casino patron on the Mississippi coast how much would a shrimp sandwich cost me if the casino r
SHMP
Monksdream Monksdream 7 minutes ago
BMY range bound
https://investorshub.advfn.com/uimage/uploads/2024/9/14/ckefvIMG_1787.gif
BMY
Flexplate Flexplate 7 minutes ago
Absolutely, that's not only going to happen with the gold here but the platinum and silver as well. I did some research last night and dug into Samsungs new solid state silver battery which will take over the electric car market. They're saying each battery will use 1 kilo of silver which will massi
NBRI
satter satter 7 minutes ago
You did not need to show your brainless.
JACKPOT JACKPOT 7 minutes ago
https://www.bloomberg.com/news/videos/2024-07-31/howard-lutnick-on-bgc-business-new-exchange-and-rates

Last chance to upgrade your POS Sonata.
BGC
Investor082 Investor082 8 minutes ago
I will admit I am wrong then. Although LP’s ASM update made it clear that they haven’t even developed a pricing model and that outside consultants needed to be hired for that. Given their execution history over the years, its fair to assume it hasn’t been initiated yet. They had 4 years since data l
ASM
Monksdream Monksdream 8 minutes ago
NUVL 52=week high
https://investorshub.advfn.com/uimage/uploads/2024/9/14/mpqbuIMG_1785.gif
art2426 art2426 9 minutes ago
LMAO, DID YOU? Because if you did READ THE FINANCIALS you would stop saying the laughable ---- GO BIEL - GO KELLY!

How is reading these posts by the 'true longs' ----- NOT FUN?!!!
BIEL
BullNBear52 BullNBear52 9 minutes ago
Do you live in a development in a metropolitan area? Have you had your car broken into in your driveway or a package stolen off your porch? If so buy a Ring doorbell and a security system.

Lost your dog or cat? Seen a raccoon or a fox in your neighborhood. They have been known to car
BIOChecker4 BIOChecker4 9 minutes ago
Missling is sloppy. His speech is sloppy, his conference calls are sloppy, he’s sloppy in interviews, his website is sloppy, he’s sloppy looking, he presents data in a sloppy way, and he runs the company in a sloppy way. Is it any wonder he’s not taken seriously by smart money biotech investors?
AVXL
DSherman DSherman 9 minutes ago
Yep, let’s talk about you some more,, lolololol!!!
Eltp
ELTP
Monksdream Monksdream 11 minutes ago
AMGN still under $400
https://investorshub.advfn.com/uimage/uploads/2024/9/14/hqsztIMG_1784.gif
AMGN
getmoreshares getmoreshares 11 minutes ago
THANKS-- YOU TOO-- IMO we have a WINNER!!!
NBRI
jxyzobrien jxyzobrien 11 minutes ago
steve rhodes
uses perrigee's and so do many TFNN
when there is no statistical edge its not useable
when geostorms are irrelevant for months they are behind useless
i want to ask steve if he uses lunar eclipse

there was post today about Putin threatening to
CountOfMeltedCrisco CountOfMeltedCrisco 11 minutes ago
"There's no fever like gold fever!"

Remember this simple truth of the human condition as
you watch the price of NBRI rise to heights thought
"impossible" and wish you'd bought more Shares at
these current prices.

NBRI! $$2024!
NBRI

Your Recent History

NASDAQ
GHRS
GH Research
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved